Claudia Praehauser

Risk factors and outcome of expanded-criteria donor kidney transplants in patients with low immunological risk.

M. Mayr, S. Schaub, P. Amico, 2013, Swiss medical weekly.

The outcome of the primary vascular access and its translation into prevalent access use rates in chronic haemodialysis patients

L. Gurke, M. Dickenmann, M. Mayr, 2012, Clinical kidney journal.

Patient-reported respiratory symptoms and pre-bronchodilator airflow limitation among smokers in Switzerland.

J. Leuppi, D. Miedinger, M. Tamm, 2010, Primary care respiratory journal : journal of the General Practice Airways Group.

Morbidity and mortality on chronic haemodialysis: a 10-year Swiss single centre analysis.

M. Dickenmann, J. Steiger, M. Mayr, 2011, Swiss medical weekly.

The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa

S. Abdulla, A. Hamad, K. Reither, 2018, PloS one.

Cohort study on the quality of oral anticoagulation therapy in chronic haemodialysis patients treated with phenprocoumon.

J. Steiger, M. Mayr, Claudia Praehauser, 2013, Swiss medical weekly.

Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study

S. Abdulla, A. Hamad, K. Reither, 2020, BMJ open diabetes research & care.

Delayed graft function is not associated with an increased incidence of renal allograft rejection

J. Steiger, M. Mayr, S. Schaub, 2012, Clinical transplantation.

Access and outcome in chronic haemodialysis: which one takes the lead - the first, the last or the one with longest lifespan? Reply to the letter to the Editor "Chronic haemodialysis: the access determines the outcome?" by Chia-Ter Chao

M. Mayr, T. Breidthardt, Claudia Praehauser, 2011 .